Troluce Capital Advisors LLC Cytokinetics Inc Put Options Transaction History
Troluce Capital Advisors LLC
- $209 Million
- Q1 2025
Put Options
1 transactions
Others Institutions Holding CYTK
# of Institutions
385Shares Held
127MCall Options Held
3.68MPut Options Held
835K-
Black Rock Inc. New York, NY14.7MShares$503 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$342 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$274 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$209 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...